NANCY RUBIN, D.O.

New patient office or other outpatient visit, 60-74 minutes

Established patient office or other outpatient visit, 40-54 minutes

Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes

Leuprolide acetate (for depot suspension), 7.5 mg

Administration of chemotherapy into vein, 1 hour or less

Established patient office or other outpatient visit, 30-39 minutes

Telephone medical discussion with physician, 21-30 minutes

Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes

Telephone medical discussion with physician, 11-20 minutes

Established patient office or other outpatient visit, 20-29 minutes

Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month

Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle

Administration of additional new drug or substance into vein, 1 hour or less

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)

Administration of additional new drug or substance into vein using push technique

Injection, pembrolizumab, 1 mg

Injection, daratumumab, 10 mg and hyaluronidase-fihj

Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle

Infusion into a vein for hydration, 31-60 minutes

Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less

Administration of chemotherapy into vein, each additional hour

Vitamin d-3 level

Irrigation of implanted venous access drug delivery device

Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional

Injection, denosumab, 1 mg

Infusion into a vein for therapy, prevention, or diagnosis, each additional hour

Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion

Influenza vaccine, quadrivalent, 0.5 ml dosage

Injection of additional new drug or substance into vein

Blood test, thyroid stimulating hormone (tsh)

Injection of drug or substance under skin or into muscle

Infusion into a vein for hydration, each additional hour

Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic

Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

Unclassified drugs

Insertion of needle into vein for collection of blood sample

Injection, fulvestrant, 25 mg

Ferritin (blood protein) level

Blood test, comprehensive group of blood chemicals

Lactate dehydrogenase (enzyme) level

Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

Injection, zoledronic acid, 1 mg

Urinalysis, manual test

Injection, darbepoetin alfa, 1 microgram (non-esrd use)

Infusion, normal saline solution , 1000 cc

Injection, carboplatin, 50 mg

Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

Injection, palonosetron hcl, 25 mcg